HALO

HALOZYME THERAPEUTICS INC

Healthcare | Mid Cap

$0.99

EPS Forecast

$261.7

Revenue Forecast

Announcing earnings for the quarter ending 2025-03-31 soon

Market expectations

EPS Expectation:

$0.99

Revenue Expectation:

$261.7

EPS Surprise Expectation:

$0.073

Revenue Surprise Expectation:

$13

Post-release price volatility - Medium

Post-release Overnight Move:

±6.5%

Post-release 1-week Move:

Expected price impact

If company results match EPS & revs consensus exactly:

If company results match Proximilar expectations exactly:

Earnings volatility

EPS standard deviation:

Revenue standard deviation:

As % of share price:

As % of market cap: